PortfoliosLab logoPortfoliosLab logo

Looking to balance out your exposure to CDNA? The ETFs below have historically moved differently from CDNA, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.

Best Diversifiers for CDNA

0 ETFs have low correlation with CDNA (below 0.3), 0 of which are negatively correlated. The least correlated is State Street SPDR S&P 500 ETF (SPY) (S&P 500) with a 1Y correlation of 0.31, down from 0.44 over 5 years.

How candidates are selected

SymbolNameCorrelation 1YCorrelation 3YCorrelation 5YRisk / Return RankCategoryCompare
State Street SPDR S&P 500 ETF0.310.380.44
67
S&P 500CDNA vs SPY
SPDR S&P Biotech ETF0.360.490.59
94
Health & Biotech EquitiesCDNA vs XBI

Rows per page

1–2 of 2

Low-Correlation Stock Ideas

The table shows companies with at least $1B in market capitalization, historical correlation data for CDNA, and a Risk / Return Rank of 50 or higher. Treat them as research candidates rather than evidence that they will offset a future decline. The least correlated is Eli Lilly and Company (LLY) (Healthcare) with a 1Y correlation of 0.12, roughly unchanged from 0.15 over 5 years.

How candidates are selected

SymbolNameCorrelation 1YCorrelation 3YCorrelation 5YRisk / Return RankSector
Eli Lilly and Company0.120.150.15
83
Healthcare
Lumen Technologies, Inc.0.130.220.23
64
Communication Services
NVIDIA Corporation0.130.210.31
56
Technology
Pulse Biosciences, Inc.0.300.310.29
88
Healthcare
AST SpaceMobile, Inc.0.300.310.32
52
Technology
See all 6 low-correlation stocks for CDNA

To view more results, upgrade your current subscription plan.

Diversification Analysis

Build a portfolio that complements CDNA

Add CDNA to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with CDNA